The top three vascular access companies in 2026 are Becton Dickinson (BD), B. Braun, and Cardinal Health.
Together, they lead a global vascular access device market that iData Research valued at $13 billion in 2025.
The category covers implantable ports, central venous catheters, PICCs, peripheral IV catheters, midlines, dialysis catheters, syringes and needles, and the accessories that support them.
This guide explains who leads, what each company sells, and what is moving the market this year.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ Who are the top vascular access companies in 2026
➜ Why BD leads the vascular access market
➜ What makes B. Braun a top vascular access company
➜ How Cardinal Health earns a top three spot in vascular access
➜ How big is the vascular access device market
Key Takeaways
- Becton Dickinson (BD) led the global vascular access market in 2025 and ranked first in 9 of the 13 device segments iData Research tracks.
- B. Braun is one of the market’s leading competitors, with a strong presence in peripheral IV catheters and central venous catheter systems.
- Cardinal Health completes the top three through its syringes and needles portfolio and selected catheter securement products.
- iData Research values the global market at $13 billion in 2025, rising to nearly $15.3 billion by 2032 at a 2.4% CAGR.
- Growth is driven more by a shift toward higher-value devices such as implantable ports, PICCs and midlines than by volume.
Who are the top vascular access companies in 2026
iData Research names Becton Dickinson (BD), B. Braun and Cardinal Health as the top three market share leaders in global vascular access.
The ranking comes from the iData Research 2026 Global Vascular Access Market report, which covers 13 device segments with 2025 as the base year.
BD leads the market and ranks first in nine of those 13 segments.
B. Braun and Cardinal Health round out the top three through very different strengths.
Other companies lead individual segments, including Teleflex in central venous catheters and Solventum in catheter securement and catheter caps.
Why BD leads the vascular access market
Becton Dickinson led the global vascular access market in 2025, with a strong presence across both core devices and accessories.
iData ranks BD first in implantable ports, port needles, PICCs, peripheral IV catheters, extended dwell catheters, midlines, dialysis catheters, tip-placement systems, and syringes and needles.
BD also ranks second in central venous catheters and catheter securement.
According to iData, ongoing innovation in vascular access, infection prevention and workflow efficiency has reinforced that leadership.
In January 2025, BD announced new investments in its U.S. manufacturing network to add capacity for syringes, needles and IV catheters.
BD says those lines will lift its domestic capacity for safety-engineered injection devices by more than 40% and for conventional syringes by more than 50%.
That same month, Carlin Clinic said it would offer needle-free blood draws using the BD PIVO Pro Needle-free Blood Collection Device.
In April 2026, BD launched the BD CentroVena One Insertion System, which it describes as the first all-in-one central venous catheter insertion device on the market.
The system brings the introducer needle, syringe, guidewire and catheter together in a single platform.
It received FDA 510(k) clearance in April 2025 and was accepted into the FDA Safer Technologies Program for Medical Devices.
What makes B. Braun a top vascular access company
B. Braun remained one of the leading competitors in global vascular access in 2025, backed by a portfolio that spans peripheral and central access.
The company has a strong presence in peripheral IV catheters and central venous catheter systems.
According to iData, integrated support for ECG-guided tip positioning strengthens its position in the PIVC, port needle, and CVC segments.
iData ranks B. Braun second in peripheral IV catheters and third in port needles, central venous catheters, and syringes and needles.
In October 2026, B. Braun launched the Introcan Safety 2 Deep Access IV Catheter, the newest addition to its ultrasound-guided deep access portfolio.
The longer catheter is designed for patients with difficult venous access and for extended therapy, and it received FDA 510(k) clearance in September 2024.
A 2025 meta-analysis of 15 studies and 1,485 patients found that ultrasound guidance significantly improved IV placement success in patients with difficult veins.
How Cardinal Health earns a top three spot in vascular access
Cardinal Health competes in vascular access mainly through its syringes and needles portfolio and selected catheter securement products.
The company uses its scale as a global manufacturer and distributor to supply high-volume consumables to hospitals and alternate-site care settings.
Its strength sits in those high-volume consumables rather than in higher-complexity device segments.
Cardinal Health sells its syringes and needles under the Monoject brand.
In November 2024, Cardinal Health said the majority of its Monoject needle and syringe portfolio is now manufactured in the U.S., backed by investments at its Norfolk, Nebraska and DeLand, Florida facilities.
How big is the vascular access device market
iData Research valued the global vascular access device market at $13 billion in 2025.
The market is forecast to grow at a CAGR of 2.4% to reach nearly $15.3 billion by 2032.
Growth is coming more from a shift in product mix than from higher volumes.
Higher-value devices such as implantable ports, PICCs and midlines are taking a larger share of total market value.
Short-term and high-volume products face more mature demand.
Aging populations and the rising prevalence of chronic conditions are increasing demand for long-term and specialty vascular access devices.
A strong focus on safety and complication reduction is also lifting long-dwell devices, securement systems and infection-prevention products.
Full segment and competitor data is available in the iData Research Global Vascular Access Device Market report.
Vascular access also features in the iData Research 2026 Top Growing MedTech Devices Forecast.
Frequently asked questions
What are the top vascular access companies?
Becton Dickinson (BD), B. Braun and Cardinal Health are the top three companies in the global vascular access market, according to iData Research.
Who is the largest vascular access company?
Becton Dickinson (BD) is the largest vascular access company by global market share in 2025.
How big is the vascular access device market?
iData Research valued the global vascular access device market at $13 billion in 2025 and expects it to reach nearly $15.3 billion by 2032.
Which company leads the central venous catheter market?
Teleflex leads the global central venous catheter market, with BD second and B. Braun third.
What devices are included in the vascular access market?
The market includes implantable ports, port needles, central venous catheters, PICCs, peripheral IV catheters, extended dwell catheters, midlines, dialysis catheters, tip-placement systems, catheter securement, antibacterial catheter patches, catheter caps, and syringes and needles.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
